Cargando…

In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment

SIMPLE SUMMARY: The vast majority of tumors originate in tissues that use different substrates and oxygen to produce energy. However, tumors are disorganized structurally and functionally, which creates areas where oxygen and nutrients are poorly available. To survive and proliferate, cancer cells a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benyahia, Zohra, Blackman, Marine C. N. M., Hamelin, Loïc, Zampieri, Luca X., Capeloa, Tania, Bedin, Marie L., Vazeille, Thibaut, Schakman, Olivier, Sonveaux, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867268/ https://www.ncbi.nlm.nih.gov/pubmed/33540599 http://dx.doi.org/10.3390/cancers13030569

Ejemplares similares

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
por: Curtis, Nicola J., et al.
Publicado: (2017)

In Vivo Anticancer Activity of AZD3965: A Systematic Review
por: Silva, Ana, et al.
Publicado: (2021)

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965
por: Braga, Marta, et al.
Publicado: (2020)

Mitochondrial Protein Cox7b Is a Metabolic Sensor Driving Brain-Specific Metastasis of Human Breast Cancer Cells
por: Blackman, Marine C. N. M., et al.
Publicado: (2022)

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
por: Beloueche-Babari, Mounia, et al.
Publicado: (2020)

Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice
por: Capeloa, Tania, et al.
Publicado: (2022)

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
por: Zampieri, Luca X., et al.
Publicado: (2021)

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
por: Noble, Richard A., et al.
Publicado: (2017)

MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity
por: Capeloa, Tania, et al.
Publicado: (2022)

Mitochondria in cancer
por: Grasso, Debora, et al.
Publicado: (2020)

MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice †
por: Capeloa, Tania, et al.
Publicado: (2022)

(+)-Catechin in a 1:2 Complex with Lysine Inhibits Cancer Cell Migration and Metastatic Take in Mice
por: Payen, Valéry L., et al.
Publicado: (2017)

The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis
por: Sheng, Xiang-xiang, et al.
Publicado: (2016)

Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
por: Cacace, Andrea, et al.
Publicado: (2016)

Preclinical Incorporation Dosimetry of [(18)F]FACH—A Novel (18)F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET
por: Sattler, Bernhard, et al.
Publicado: (2020)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Is translational research compatible with preclinical publication strategies?
por: Linder, Stig, et al.
Publicado: (2006)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?
por: d’Hose, Donatienne, et al.
Publicado: (2022)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity
por: Weber, Daniela D., et al.
Publicado: (2022)

Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation
por: Åstrand, Annika, et al.
Publicado: (2022)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
por: Sonveaux, Pierre, et al.
Publicado: (2012)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model
por: Ku, Bo Mi, et al.
Publicado: (2018)

The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E
por: Namjoshi, Dhananjay R., et al.
Publicado: (2013)

Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
por: Strickaert, A, et al.
Publicado: (2017)

Radiosynthesis and validation of (±)-[(18)F]-3-fluoro-2-hydroxypropionate ([(18)F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors
por: Van Hée, Vincent F., et al.
Publicado: (2017)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

MR-compatibility study of a preclinical digital PET/MRI insert
por: Wehner, Jakob, et al.
Publicado: (2014)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
por: Davis, S. Lindsey, et al.
Publicado: (2022)

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
por: Illuzzi, Giuditta, et al.
Publicado: (2022)

Marked Seizure Reduction after MCT Supplementation
por: Azzam, Raed, et al.
Publicado: (2013)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3eolqpmjrhmd38gbt8ks8ujf3